Unitas Global Acquires INAP's Network Business Assets
9.5.2022 14:30:00 EEST | Business Wire | Press release
Unitas Global, a Digital Alpha portfolio company, announces today that it has acquired INAP’s Network Business assets, including INAP Japan, enhancing its portfolio of network service offerings that enable hybrid cloud environments. The combination of these two companies creates a high-growth next generation networking platform focused on simplifying the way customers buy network connectivity to enable the seamless movement of data between various cloud and on-premises environments.
The combination of the INAP network technologies, including its patented, intelligent routing software, Managed Internet Route Optimizer (MIRO), with Unitas Global's automated design and pricing platform, Unitas Nexus™, and its global network, Unitas Reach™, creates a compelling offer to meet the needs of enterprises modernizing their digital infrastructure. In addition, this acquisition provides Unitas Global with a significant expansion of over a thousand multinational enterprise customers as well as global network serving 18 markets with Performance IP™.
"We are thrilled to have completed the acquisition of INAP's Network Business and excited to welcome their customers, vendors and employees to the Unitas Global team," comments Patrick Shutt, CEO of Unitas Global. "The disruptive nature of Unitas' networking services strategy that enables hybrid cloud environments has become increasingly self-evident in the market. This acquisition is the next step to become the market leader redefining an agile hybrid cloud for the enterprise," comments Grant Kirkwood, CTO of Unitas Global.
An additional benefit of the transaction is the synergy of INAP becoming a strategic customer of Unitas Global. INAP will continue to offer high-performance connectivity services alongside its colocation and cloud solutions, further expanding its portfolio with Unitas Reach™ network transformation solutions, including the most recent alliance announcement with PacketFabric.
“The transaction is a true win-win for everyone involved. Unitas Global will continue to provide the high-quality services that customers enjoy today while investing in new solutions to enable further network transformation tomorrow," comments Mike Sicoli, CEO of INAP. "We also look forward to partnering with Unitas Global to bring an expanded portfolio of connectivity offerings to our colocation and cloud customers."
"The acquisition of INAP’s Network Business assets is a powerful proof point of Digital Alpha's commitment to investing in and developing transformative next generation networks that provide a more holistic networking-as-a-service solution in the currently fragmented marketplace," states Rick Shrotri Managing Partner of Digital Alpha Advisors.
For more information, visit: https://www.unitasglobal.com/
About Unitas Global
Unitas Global is a next-generation network service provider offering automated ubiquitous edge access to cloud everywhere. The combination of its Unitas Nexus™ platform and global Unitas Reach™ network provides the most transformative network environments that are easy to design, procure, and fully managed. Analyzing price and performance requirements in real-time makes Unitas Nexus™ one of the most advanced go-to-market platforms for MSPs, hyperscale cloud providers, and datacenter operators worldwide. Unitas Reach™ access, IP, and SDN provide cost-optimized network connectivity with the agility needed to scale quickly and support the growing demands of applications on network architectures, performance, and costs. Unitas Global is a Digital Alpha Advisors portfolio company. Learn more at unitasglobal.com or connect with Unitas at LinkedIn, Twitter, and its Blog.
About INAP
INAP is a global provider of performance-driven, secure hybrid infrastructure solutions, enabling technology leaders to simplify their cloud journeys and accelerate innovation. INAP's expansive suite of bare metal cloud, modern data center, optimized network and security solutions help businesses flexibly and reliably move workloads to the right destination at the right time to maximize the results of their IT strategy. For more information, visit www.inap.com
About Digital Alpha Advisors, LLC
Digital Alpha Advisors, LLC is an investment firm focused on digital infrastructure required by the rapidly expanding digital economy, with total assets under management of over $1.5B. The firm has a strategic collaboration agreement with Cisco Systems, Inc. and has partnered with other leading Silicon Valley firms. Digital Alpha believes it is the first firm focused on making private equity investments in the significant growth opportunities required to underpin the Digital Economy, including next generation communications networks, IoT platforms for urban infrastructure, and cloud-based data management platforms. Digital Alpha was founded in 2017 by Rick Shrotri, former Head of the Global Infrastructure Funds (GIF) team at Cisco, and closed its latest Fund – Digital Alpha Fund II, LP – in early 2021. For more information, please visit www.digitalalpha.net.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220508005058/en/
Contact information
Media Contacts for Unitas Global:
Ilissa Miller
iMiller Public Relations
Tel: +1.866.307.2510
Email: Unitasglobal@imillerpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
